𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line

✍ Scribed by Hongtao Lv; Chuzhong Li; Songbai Gui; Meizhen Sun; Dan Li; Yazhuo Zhang


Publisher
Springer US
Year
2010
Tongue
English
Weight
474 KB
Volume
102
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The effects of type beta transforming gr
✍ Eirik Helseth; Geirmund Unsgaard; Are Dalen; Randi Vik πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 582 KB

Type beta transforming growth factor (B-TGF) is a potent growth inhibitor to many human tumor cell lines. Very little is known about the mechanism for this growth inhibitory action of B-TGF. We here report the effect of B-TGF on proliferation and epidermal growth factor receptor (R-EGF) expression i

Effects of cell density and phorbol este
✍ Angie Rizzino; Claire Huebert; Charles Kuszynski; Phillip J. Wilder πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 662 KB

Previously, it has been shown that the binding of epidermal growth factor (EGF) by a wide range of cells decreases as cell density increases. In this report, we demonstrate that KB cells treated chronically with phorbol esters continue to exhibit decreases in EGF receptor binding as cell density inc

The effects of estrogen receptors Ξ±- and
✍ Dr. D. Somjen; S. Katzburg; O. Sharon; M. Grafi-Cohen; E. Knoll; N. Stern πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 520 KB

## Abstract In cultured human osteoblasts estradiol‐17Ξ² (E2) modulated DNA synthesis, the specific activity of creatine kinase BB (CK), 12 and 15 lipoxygenase (LO) mRNA expression and formation of 12‐ and 15‐hydroxyeicosatetraenoic acid (HETE). We now investigate the response of human bone cell lin

Effects of tyrosine kinase inhibitor, er
✍ Naoki Takekura; Wataru Yasui; Eikai Kyo; Kazuhiro Yoshida; Takashi Kameda; Yasuh πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 571 KB

The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in